Description
This transcript captures a discussion led by Andrew Price and Tim Board regarding the Rejoin study, a research initiative aiming to evaluate surgical pathways for elective hip and knee replacement surgeries in the context of COVID-19. The conversation highlights the impact of the pandemic on surgical practices, including risk assessment and patient communication regarding the likelihood of contracting COVID-19 during elective surgeries. Tim Board emphasizes the importance of understanding evolving risks and the necessity for real-time data to guide decision-making in surgical practices. They outline data collection methods, the study's objectives to analyze postoperative complications, and the need for feedback mechanisms to ensure patient safety. The presenters, associated with the British Hip Society and other academic institutions, express their commitment to comprehensive data gathering to improve patient outcomes and mitigate risks related to COVID-19.
DOI: 10.1302/3114-210346